O’Shaughnessy, J., Petrakova, K., Sonke, G. S., Conte, P., Arteaga, C. L., Cameron, D. A., . . . Hortobagyi, G. N. (2017). Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2− advanced breast cancer in the randomized MONALEESA-2 trial. Breast Cancer Res Treat.

O’Shaughnessy, Joyce, et al. "Ribociclib Plus Letrozole Versus Letrozole Alone in Patients With De Novo HR+, HER2− Advanced Breast Cancer in the Randomized MONALEESA-2 Trial." Breast Cancer Res Treat 2017.

O’Shaughnessy, Joyce, et al. "Ribociclib Plus Letrozole Versus Letrozole Alone in Patients With De Novo HR+, HER2− Advanced Breast Cancer in the Randomized MONALEESA-2 Trial." Breast Cancer Res Treat 2017.